EWA
NUVB icon

EverSource Wealth Advisors’s Nuvation Bio NUVB Stock Holding History

EverSource Wealth Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2K Sell
4,264
-37
-0.9% -$181 ﹤0.01% 2293
2026
Q1 		$18.5K Buy
4,301
+312
+8% +$1.74K ﹤0.01% 2552
2025
Q4 		$35.7K Hold
3,989
– – ﹤0.01% 1985
2025
Q3 		$14.8K Buy
3,989
+1,771
+80% +$4.83K ﹤0.01% 2576
2025
Q2 		$4.33K Buy
2,218
+804
+57% +$1.68K ﹤0.01% 3222
2025
Q1 		$2.49K Sell
1,414
-10,010
-88% -$22.8K ﹤0.01% 2832
2024
Q4 		$30.4K Buy
11,424
+329
+3% +$847 ﹤0.01% 1407
2024
Q3 		$25.4K Hold
11,095
– – ﹤0.01% 1366
2024
Q2 		$42.5K Buy
11,095
+10,000
+913% +$30.5K ﹤0.01% 1166
2024
Q1 		$3.27K Hold
1,095
– – ﹤0.01% 2218
2023
Q4 		$1.65K Hold
1,095
– – ﹤0.01% 2229
2023
Q3 		$1.47K Sell
1,095
-1,121
-51% -$1.87K ﹤0.01% 2096
2023
Q2 		$3.99K Buy
2,216
+1,221
+123% +$2.08K ﹤0.01% 1820
2023
Q1 		$1.65K Hold
995
– – ﹤0.01% 1995
2022
Q4 		$1.91K Buy
+995
New +$2.01K ﹤0.01% 1920

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

EverSource Wealth Advisors's NUVB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Nuvation Bio (NUVB) stake by 0.86% in Q2 2026, selling an estimated $181 and leaving 4,264 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

EverSource Wealth Advisors first reported a position in NUVB in Q4 2022 and has held it in 15 quarters since. The position peaked at $42.5K in Q2 2024. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • EverSource Wealth Advisors held 4,264 shares of Nuvation Bio worth $24.2K as of Q2 2026.
  • EverSource Wealth Advisors sold 37 Nuvation Bio shares in Q2 2026, an estimated $181.
  • Nuvation Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2293 holding.
  • EverSource Wealth Advisors first reported a position in Nuvation Bio in Q4 2022 and has held it in 15 quarters since.
  • EverSource Wealth Advisors's Nuvation Bio position peaked at $42.5K in Q2 2024.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.